Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.
Publication
, Journal Article
Miksad, RA; Abernethy, AP
Published in: Clinical pharmacology and therapeutics
February 2018
The role of real-world evidence (RWE) in regulatory, drug development, and healthcare decision-making is rapidly expanding. Recent advances have increased the complexity of cancer care and widened the gap between randomized clinical trial (RCT) results and the evidence needed for real-world clinical decisions. Instead of remaining invisible, data from the >95% of cancer patients treated outside of clinical trials can help fill this void.
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clinical pharmacology and therapeutics
DOI
EISSN
1532-6535
ISSN
0009-9236
Publication Date
February 2018
Volume
103
Issue
2
Start / End Page
202 / 205
Related Subject Headings
- Translational Research, Biomedical
- Risk Assessment
- Pharmacology & Pharmacy
- Patient Safety
- Models, Theoretical
- Learning
- Humans
- Evidence-Based Medicine
- Drug Discovery
- Drug Development
Citation
APA
Chicago
ICMJE
MLA
NLM
Miksad, R. A., & Abernethy, A. P. (2018). Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clinical Pharmacology and Therapeutics, 103(2), 202–205. https://doi.org/10.1002/cpt.946
Miksad, Rebecca A., and Amy P. Abernethy. “Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.” Clinical Pharmacology and Therapeutics 103, no. 2 (February 2018): 202–5. https://doi.org/10.1002/cpt.946.
Miksad RA, Abernethy AP. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clinical pharmacology and therapeutics. 2018 Feb;103(2):202–5.
Miksad, Rebecca A., and Amy P. Abernethy. “Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.” Clinical Pharmacology and Therapeutics, vol. 103, no. 2, Feb. 2018, pp. 202–05. Epmc, doi:10.1002/cpt.946.
Miksad RA, Abernethy AP. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clinical pharmacology and therapeutics. 2018 Feb;103(2):202–205.
Published In
Clinical pharmacology and therapeutics
DOI
EISSN
1532-6535
ISSN
0009-9236
Publication Date
February 2018
Volume
103
Issue
2
Start / End Page
202 / 205
Related Subject Headings
- Translational Research, Biomedical
- Risk Assessment
- Pharmacology & Pharmacy
- Patient Safety
- Models, Theoretical
- Learning
- Humans
- Evidence-Based Medicine
- Drug Discovery
- Drug Development